Publications by authors named "Ishankumar Soni"

Caspases are a family of enzymes that regulate biological processes such as inflammation and programmed cell death, through proteolysis. For example, in the intrinsic pathway of apoptosis, cell death signaling involves cytochrome release from the mitochondria, which leads to the activation of caspase-9 and eventually the executioners caspase-3 and -7. One key step in our understanding of these proteases is to identify their respective protein substrates.

View Article and Find Full Text PDF

Studying the interactions between a protease and its protein substrates at a molecular level is crucial for identifying the factors facilitating selection of particular proteolytic substrates and not others. These selection criteria include both the sequence and the local context of the substrate cleavage site where the active site of the protease initially binds and then performs proteolytic cleavage. Caspase-9, an initiator of the intrinsic apoptotic pathway, mediates activation of executioner procaspase-3 by cleavage of the intersubunit linker (ISL) at site IETD↓S.

View Article and Find Full Text PDF
Article Synopsis
  • Acyl phosphates, like ATPAc, are useful for studying how certain nucleotides bind to proteins by modifying specific lysine residues, which can happen even in proteins without previously identified binding sites.
  • The study shows that ATPAc specifically acylates the lysine at position 133 (K133) of procaspase-6 in Jurkat cells, influenced by interactions at the protein's dimer interface involving a conserved tyrosine residue (Y198).
  • A mutation (Y198A) that alters this interaction prevents acylation at K133 but does not affect the activity of the active form of caspase-6, suggesting that ATP could play a key role as an endogenous ligand at this previously un
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of Caspase-6 (Casp6) and its variants R65W and G66R as potential therapeutic targets for Alzheimer’s Disease (AD) and cognitive decline with age.
  • * Researchers found that both variants significantly reduced Casp6 activity and stability, with G66R acting as an inhibitor of the normal Casp6 function.
  • * The findings suggest that full Casp6 activity may not be crucial for human health and that Casp6 inhibitors could be effective in treating neurodegeneration associated with aging and AD.
View Article and Find Full Text PDF